How does selenium supplementation benefit patients with Hashimoto's thyroiditis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 3, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question

Selenium Supplementation in Hashimoto's Thyroiditis

Current clinical guidelines do not support routine selenium supplementation for Hashimoto's thyroiditis, as there is insufficient outcome data to justify its use despite some biochemical effects. 1

Guideline Position

The 2012 AACE/ATA clinical practice guidelines explicitly state that "there are simply not enough outcome data to suggest a role at the present time for routine selenium use to prevent or treat hypothyroidism in any population" despite selenium's "notable theoretical potential." 1 This recommendation carries a Grade D, BEL 4 rating.

Mechanism of Action

Selenium functions as an essential component of selenoenzymes involved in:

  • Antioxidant pathways that may reduce oxidative stress in thyroid tissue
  • Thyroid hormone deiodination (conversion of T4 to active T3)
  • Oxidation-reduction reactions that modulate immune function 1

These biochemical roles explain why selenium has been investigated for autoimmune thyroid disease, but mechanism alone does not translate to clinical benefit.

What the Research Actually Shows

Antibody Reduction (Not a Clinical Outcome)

A 2010 meta-analysis found that selenium supplementation (typically 200 µg/day for 3 months) significantly reduced anti-TPO antibody titers (weighted mean difference: -271.09 IU/mL) in patients already on levothyroxine. 2 However, lowering antibody levels does not necessarily improve morbidity, mortality, or quality of life—the outcomes that actually matter to patients.

Subjective Well-Being (Weak Evidence)

The same meta-analysis reported improved mood or well-being (risk ratio: 2.79), but this finding was based on only three studies with subjective endpoints. 2

No Impact on Thyroid Function or Morphology

Critically, selenium supplementation did not change:

  • Levothyroxine dosing requirements
  • Thyroid gland ultrasonographic appearance
  • Thyroid hormone levels (TSH, FT4, FT3) in most studies 1, 2

Concerning Recent Data

A 2026 large-scale retrospective cohort study (2,347 matched patients per group) found selenium supplementation was associated with:

  • Persistently higher TSH and anti-TPO levels (opposite of intended effect)
  • Increased incidence of other autoimmune disorders (RR 1.33), particularly Sjögren's syndrome and psoriasis
  • Increased all-cause mortality (RR 1.38,95% CI 1.09-2.03) 3

While this study lacked baseline selenium measurements (a significant limitation), these findings raise serious safety concerns.

Geographic Variability

The European trial showing benefit used 200 µg/day selenomethionine in a population that may have had baseline selenium deficiency. 1 Dietary selenium intake varies dramatically worldwide, making results from selenium-deficient populations non-generalizable to selenium-replete regions like the United States.

Potential Harms

Beyond the mortality signal in 3, selenium supplementation has been associated with:

  • Increased diabetes risk in follow-up studies 1
  • Paradoxical worsening of autoimmunity in some patients 3, 4
  • No established safe upper limit for long-term use in this population

Clinical Bottom Line

Do not routinely recommend selenium supplementation for Hashimoto's thyroiditis. The evidence shows:

  1. No improvement in thyroid function (the outcome that determines levothyroxine dosing)
  2. No improvement in thyroid morphology (structural disease progression)
  3. Antibody reduction without clinical benefit (surrogate endpoint only)
  4. Potential for harm including increased mortality and autoimmune comorbidity 3

When to Consider Testing

If a patient insists on supplementation or has risk factors for selenium deficiency (malabsorption, strict vegan diet, residence in selenium-poor regions), measure baseline serum selenium levels first. Only supplement if documented deficiency exists (<80 µg/L), and monitor closely for adverse effects.

Common Pitfall

Patients often equate lower antibody titers with disease improvement. Explain that anti-TPO levels do not predict symptom severity, disease progression, or need for treatment adjustments. The goal is optimizing thyroid hormone replacement based on TSH and clinical status—not chasing antibody numbers.

References

1
Guideline

clinical practice guidelines for hypothyroidism in adults: cosponsored by the american association of clinical endocrinologists and the american thyroid association.

Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologist, 2012

2
Research

Selenium supplementation in the treatment of Hashimoto's thyroiditis: a systematic review and a meta-analysis.

Thyroid : official journal of the American Thyroid Association, 2010

Related Questions

In a patient with autoimmune thyroiditis on stable levothyroxine and normal TSH, should selenium and myo‑inositol be added as adjunct therapy?
What supplements are safe for a patient with thyroid disease or who is taking antithyroid medication?
In an 81‑year‑old man with markedly elevated thyroglobulin antibodies, normal thyroid peroxidase antibodies, and normal thyroid‑stimulating hormone (TSH) and free thyroxine (free T4) levels on [date], should selenium supplementation be initiated?
How does inositol affect thyroid antibodies in autoimmune thyroid conditions like Hashimoto's thyroiditis?
Can a person with Hashimoto's thyroiditis take Orgain protein powder?
How should I evaluate and rule out septic arthritis?
When is risperidone indicated, and what are the recommended dosing, monitoring, and contraindications for its use in adults and pediatric patients?
For a patient with lumbar segmental and somatic dysfunction and scoliosis who now has lower back pain with right‑leg numbness and tingling, what is the differential diagnosis and appropriate treatment plan?
How should I enter the diagnosis on a Labcorp order for vitamin B12, folate, and vitamin D testing?
Is there a tumor called chordoma?
What is the recommended intramuscular ceftriaxone dosing for cellulitis, including adult and pediatric regimens, contraindications, and need for additional MRSA coverage?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.